Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ZARODENT ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   18.1% 20.1% 21.7% 13.2% 11.3% 19.2% 15.5% 7.1%   Credit score (0-100)   9 6 5 17 20 6 12 10   Credit rating   B C C B B C B BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   717 635 401 758 693 461 0.0 0.0   EBITDA   -22.0 46.1 -119 250 203 -74.6 0.0 0.0   EBIT   -55.1 46.1 -119 250 203 -74.6 0.0 0.0   Pre-tax profit (PTP)   -63.2 38.2 -134.9 215.9 171.5 -81.9 0.0 0.0   Net earnings   -63.2 38.2 -134.9 215.9 171.5 -81.9 0.0 0.0   Pre-tax profit without non-rec. items   -63.2 38.2 -135 216 171 -81.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -794 -756 -891 -675 -504 -586 -636 -636   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 636 636   Balance sheet total (assets)   210 182 165 317 392 249 0.0 0.0   Net Debt   -119 -77.4 -66.0 -251 -22.1 -83.0 636 636     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   717 635 401 758 693 461 0.0 0.0   Gross profit growth   -5.1% -11.4% -36.9% 89.0% -8.5% -33.4% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   210 182 165 317 392 249 0 0   Balance sheet change%   -57.3% -13.5% -9.1% 91.5% 23.6% -36.6% -100.0% 0.0%   Added value   -22.0 46.1 -119.4 250.4 202.9 -74.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -66 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -7.7% 7.3% -29.8% 33.1% 29.3% -16.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -4.9% 4.7% -12.0% 24.4% 21.5% -8.6% 0.0% 0.0%   ROI %   -280.9% 0.0% -1,265.2% 687.2% 382.7% -142.5% 0.0% 0.0%   ROE %   -18.0% 19.5% -77.6% 89.5% 48.4% -25.6% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   -79.1% -80.6% -84.3% -68.1% -56.3% -70.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   542.9% -167.9% 55.3% -100.0% -10.9% 111.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   41.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   0.2 0.2 0.2 0.3 0.1 0.3 0.0 0.0   Current Ratio   0.2 0.2 0.2 0.3 0.5 0.3 0.0 0.0   Cash and cash equivalent   119.4 77.4 66.0 250.5 22.1 83.0 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -794.4 -756.1 -872.2 -621.1 -451.6 -532.9 -317.8 -317.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -22 46 -119 250 203 -75 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -22 46 -119 250 203 -75 0 0   EBIT / employee   -55 46 -119 250 203 -75 0 0   Net earnings / employee   -63 38 -135 216 171 -82 0 0